These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 26473653)

  • 1. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics.
    Goyanes A; Wang J; Buanz A; Martínez-Pacheco R; Telford R; Gaisford S; Basit AW
    Mol Pharm; 2015 Nov; 12(11):4077-84. PubMed ID: 26473653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets.
    Goyanes A; Kobayashi M; Martínez-Pacheco R; Gaisford S; Basit AW
    Int J Pharm; 2016 Nov; 514(1):290-295. PubMed ID: 27863674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
    Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
    Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of geometry on drug release from 3D printed tablets.
    Goyanes A; Robles Martinez P; Buanz A; Basit AW; Gaisford S
    Int J Pharm; 2015 Oct; 494(2):657-663. PubMed ID: 25934428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing.
    Li Q; Wen H; Jia D; Guan X; Pan H; Yang Y; Yu S; Zhu Z; Xiang R; Pan W
    Int J Pharm; 2017 Jun; 525(1):5-11. PubMed ID: 28377316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
    Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
    Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrusion 3D Printing of Paracetamol Tablets from a Single Formulation with Tunable Release Profiles Through Control of Tablet Geometry.
    Khaled SA; Alexander MR; Irvine DJ; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ
    AAPS PharmSciTech; 2018 Nov; 19(8):3403-3413. PubMed ID: 30097806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing.
    Skowyra J; Pietrzak K; Alhnan MA
    Eur J Pharm Sci; 2015 Feb; 68():11-7. PubMed ID: 25460545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms.
    Wang J; Goyanes A; Gaisford S; Basit AW
    Int J Pharm; 2016 Apr; 503(1-2):207-12. PubMed ID: 26976500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing.
    Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA
    Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
    Sadia M; Sośnicka A; Arafat B; Isreb A; Ahmed W; Kelarakis A; Alhnan MA
    Int J Pharm; 2016 Nov; 513(1-2):659-668. PubMed ID: 27640246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing.
    Goyanes A; Chang H; Sedough D; Hatton GB; Wang J; Buanz A; Gaisford S; Basit AW
    Int J Pharm; 2015 Dec; 496(2):414-20. PubMed ID: 26481468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
    Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
    Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective laser sintering (SLS) 3D printing of medicines.
    Fina F; Goyanes A; Gaisford S; Basit AW
    Int J Pharm; 2017 Aug; 529(1-2):285-293. PubMed ID: 28668582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.
    Okwuosa TC; Pereira BC; Arafat B; Cieszynska M; Isreb A; Alhnan MA
    Pharm Res; 2017 Feb; 34(2):427-437. PubMed ID: 27943014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
    Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
    Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
    Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fused-filament 3D printing (3DP) for fabrication of tablets.
    Goyanes A; Buanz AB; Basit AW; Gaisford S
    Int J Pharm; 2014 Dec; 476(1-2):88-92. PubMed ID: 25275937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.